Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ActiRhino Pastilles
- Development stage
- Unknown
- Lead developer
- Laboratoires Grimberg
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
ActiRhino Pastilles (also marketed as ActiRhino Pastilles Maux de gorge) is an over-the-counter medical device developed and marketed by Laboratoires Grimberg. Formulated as sugar-free, cherry-flavored lozenges, it is indicated for the symptomatic relief of sore throat, dry cough, and hoarseness in adults and children aged 6 years and older. The pastilles contain a natural combination of Iceland moss (Cetraria islandica) extract, mallow (Malva sylvestris) extract, menthol, and vitamin C. Iceland moss and mallow are rich in mucilages that form a protective, hydrating film over the irritated oropharyngeal mucosa, shielding it from inflammatory triggers and promoting tissue regeneration. Menthol provides an immediate cooling and local soothing effect, while vitamin C offers antioxidant support.
- Brand names
- ActiRhino Maux de GorgeActiRhino PastillesActiRhino Pastilles Maux de gorge
02
Targets
TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV3 (Transient receptor potential vanilloid subtype 3)CaV (Voltage-gated calcium channel protein complex)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on ActiRhino Pastilles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ActiRhino Pastilles.